These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6980881)

  • 1. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.
    Brower MS; Harpel PC
    J Biol Chem; 1982 Aug; 257(16):9849-54. PubMed ID: 6980881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.
    Harpel PC; Cooper NR
    J Clin Invest; 1975 Mar; 55(3):593-604. PubMed ID: 123251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary structure of the reactive site of human C1-inhibitor.
    Salvesen GS; Catanese JJ; Kress LF; Travis J
    J Biol Chem; 1985 Feb; 260(4):2432-6. PubMed ID: 3919001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase.
    Catanese J; Kress LF
    Biochim Biophys Acta; 1984 Aug; 789(1):37-43. PubMed ID: 6432051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
    Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
    J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structural basis for neutrophil inactivation of C1 inhibitor.
    Pemberton PA; Harrison RA; Lachmann PJ; Carrell RW
    Biochem J; 1989 Feb; 258(1):193-8. PubMed ID: 2930506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.
    Donaldson VH; Harrison RA; Rosen FS; Bing DH; Kindness G; Canar J; Wagner CJ; Awad S
    J Clin Invest; 1985 Jan; 75(1):124-32. PubMed ID: 3965500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edema.
    Harpel PC; Hugli TE; Cooper NR
    J Clin Invest; 1975 Mar; 55(3):605-11. PubMed ID: 123252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.
    Weiss V; Engel J
    Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):295-301. PubMed ID: 6602754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.
    Nilsson T; Sjöholm I; Wiman B
    Biochem J; 1983 Sep; 213(3):617-24. PubMed ID: 6604523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
    Kolev K; Léránt I; Tenekejiev K; Machovich R
    J Biol Chem; 1994 Jun; 269(25):17030-4. PubMed ID: 7516329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor.
    Stief TW; Aab A; Heimburger N
    Thromb Res; 1988 Mar; 49(6):581-9. PubMed ID: 2455361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.
    Smith MA; Kerr MA
    Immunology; 1985 Nov; 56(3):561-70. PubMed ID: 2934317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and functional characterization of a fragment of C1-s containing the epidermal growth factor homology region.
    Thielens NM; Van Dorsselaer A; Gagnon J; Arlaud GJ
    Biochemistry; 1990 Apr; 29(14):3570-8. PubMed ID: 2141278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties.
    Reboul A; Prandini MH; Colomb MG
    Biochem J; 1987 May; 244(1):117-21. PubMed ID: 3311024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes.
    Brower MS; Harpel PC
    Blood; 1983 May; 61(5):842-9. PubMed ID: 6219725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens.
    Molla A; Akaike T; Maeda H
    Infect Immun; 1989 Jun; 57(6):1868-71. PubMed ID: 2656524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.